Telford, C., Bertranou, E., Large, S., Phelps, H., Ekman, M., & Livings, C. (2019). Cost-Effectiveness Analysis of Fulvestrant 500 mg in Endocrine Therapy-Naïve Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer in the UK. Pharmacoecon Open.
Citação norma ChicagoTelford, Claire, Evelina Bertranou, Samuel Large, Hilary Phelps, Mattias Ekman, and Christopher Livings. "Cost-Effectiveness Analysis of Fulvestrant 500 mg in Endocrine Therapy-Naïve Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer in the UK." Pharmacoecon Open 2019.
Citação norma MLATelford, Claire, et al. "Cost-Effectiveness Analysis of Fulvestrant 500 mg in Endocrine Therapy-Naïve Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer in the UK." Pharmacoecon Open 2019.